Prospective Randomized Comparison of Coronary Bypass Grafting With Minimal Extracorporeal Circulation System (MECC) Versus Off-Pump Coronary Surgery

Background— We aimed to evaluate the clinical results and biocompatibility of the minimal extracorporeal circulation system (MECC) compared with off-pump coronary revascularization (OPCABG). Methods and Results— In a prospective randomized study, 150 patients underwent coronary surgery with the use of MECC and 150 underwent OPCABG. End points were (1) circulating markers of inflammation and organ injury, (2) operative results, and (3) outcome at 1-year follow-up. Operative mortality and morbidity were comparable between the groups. Release of inflammatory markers was similar between groups at all time points (peak interleukin-6 167.2±13.5 versus 181±6.5 pg/mL, P=0.14, OPCABG versus MECC group, respectively). Peak creatine kinase was 419.3±103.5 versus 326±84.2 mg/dL (P=0.28), and peak S-100 protein was 0.13±0.08 versus 0.29±0.1 pg/mL (P=0.058, OPCABG versus MECC group, respectively). Length of hospital stay and use of blood products were similar between groups. Two cases of angina recurrence at 1 year in the MECC group were observed versus 5 cases observed in the OPCABG group (P=0.44). A residual perfusion defect at myocardial nuclear scan was less frequent among patients in the MECC group (3 versus 9 cases, P=0.14; odds ratio 0.32, 95% confidence interval 0.07 to 1.32). Six (OPCABG group) versus 3 (MECC group) coronary grafts were occluded or severely stenotic at 1 year (P=0.33, odds ratio 0.47, 95% confidence interval 0.09 to 2.14). Conclusions— Clinical results of coronary revascularization with MECC are optimal when this procedure is performed by experienced teams. Postoperative morbidity is comparable to that with OPCABG. MECC is associated with little pump-related systemic and organ injury. It may achieve the benefits of OPCABG (less morbidity in high-risk patients) while facilitating complete revascularization in the case of complex lesions unsuitable for OPCABG.

[1]  D. Grobbee,et al.  Cognitive and cardiac outcomes 5 years after off-pump vs on-pump coronary artery bypass graft surgery. , 2007, JAMA.

[2]  O. Wagner,et al.  Endocrine function is not impaired in patients with a continuous MicroMed-DeBakey axial flow pump. , 2007, The Journal of thoracic and cardiovascular surgery.

[3]  H. Takagi,et al.  Off-pump coronary artery bypass sacrifices graft patency: meta-analysis of randomized trials. , 2007, The Journal of thoracic and cardiovascular surgery.

[4]  E. Marcantonio,et al.  Serologic Markers of Brain Injury and Cognitive Function After Cardiopulmonary Bypass , 2006, Annals of surgery.

[5]  N. Tanaka,et al.  Equivalence of the Acute Cytokine Surge and Myocardial Injury after Coronary Artery Bypass Grafting with and without a Novel Extracorporeal Circulation System , 2005, The Journal of international medical research.

[6]  A. Liebold,et al.  Four years' experience with a miniaturized extracorporeal circulation system and its influence on clinical outcome. , 2004, Artificial organs.

[7]  C. Tribouilloy,et al.  Aortic valve replacement with the minimal extracorporeal circulation (Jostra MECC System) versus standard cardiopulmonary bypass: a randomized prospective trial. , 2004, The Journal of thoracic and cardiovascular surgery.

[8]  L. Aarts,et al.  Mini extracorporeal circuit for coronary artery bypass grafting: initial clinical and biochemical results , 2004, Perfusion.

[9]  F. Trojette,et al.  Clinical experience with the mini-extracorporeal circulation system: an evolution or a revolution? , 2004, The Annals of thoracic surgery.

[10]  G. Biondi-Zoccai,et al.  Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence. , 2004, European Journal of Cardio-Thoracic Surgery.

[11]  J. Ornato,et al.  ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). , 2004, Journal of the American College of Cardiology.

[12]  G. Tangen,et al.  Heparin-coated circuits and reduced systemic anticoagulation applied to 2500 consecutive first-time coronary artery bypass grafting procedures. , 2003, The Annals of thoracic surgery.

[13]  O. Ponzio,et al.  Totally minimized extracorporeal circulation: an important benefit for coronary artery bypass grafting in Jehovah's witnesses. , 2003, The heart surgery forum.

[14]  O. Ponzio,et al.  Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[15]  C. Triggs,et al.  Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. , 2002, The Journal of thoracic and cardiovascular surgery.

[16]  M. di Mauro,et al.  Myocardial revascularization with and without cardiopulmonary bypass in multivessel disease: impact of the strategy on early outcome. , 2001, The Annals of thoracic surgery.

[17]  R. Anderson,et al.  The effect of cardiotomy suction on the brain injury marker S100beta after cardiopulmonary bypass. , 2000, The Annals of thoracic surgery.

[18]  J. von der Emde,et al.  Reducing the Post-Pump Syndrome by Using Heparin-Coated Circuits, Steroids, or Aprotinin , 1999, The Thoracic and cardiovascular surgeon.

[19]  S. Zahler,et al.  Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass. , 1999, Cardiovascular research.

[20]  O. Taşdemír,et al.  Coronary artery bypass grafting on the beating heart without the use of extracorporeal circulation: review of 2052 cases. , 1998, The Journal of thoracic and cardiovascular surgery.

[21]  R. Shemin,et al.  Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits. , 1998, The Annals of thoracic surgery.

[22]  E. Fosse,et al.  Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activation. , 1996, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[23]  P. Everts,et al.  Systemic blood activation with open and closed venous reservoirs. , 1995, The Annals of thoracic surgery.